Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: A radiomics-based deep learning approach to predict progression free-survival after tyrosine kinase inhibitor therapy in non-small cell lung cancer

Fig. 2

Distribution of personalized PFS curves predicted by the DeepSurv models. The estimated personalized PFS curves of patients in training set, testing set, and average of personalized PFS curves in testing set based on (a) radiomic, (b) clinical, and (c) combined model, respectively. The red curves in the figure represented the patients with PFS better than median PFS, and blue curves indicated the patients with PFS poorer than median PFS

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us